Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer patients' own tumor soldiers may halt disease in new trial

NCT ID NCT06455917

Recruiting now Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 25 times

Summary

This study tests a treatment that uses immune cells taken from a patient's own lung tumor. These cells are grown in large numbers and then put back into the patient to attack the cancer. The goal is to see if this approach can stop or slow the cancer from growing in 30 adults with advanced non-small cell lung cancer who have already tried other treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Medical Oncology, University Hospital Basel

    RECRUITING

    Basel, Canton of Basel-City, 4031, Switzerland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

LUNG CANCER (NSCLC) NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER